Atrial fibrillation and troponin elevation: It's time to give up the chase to diagnosis and step forward with prognosis

Published:February 06, 2022DOI:
      Atrial fibrillation (AF) is the most common sustained arrhythmia with an estimated prevalence in adults as high as 4%. AF negatively affects the quality of life and it is associated with incident adverse cardiovascular events and two-fold higher mortality. Lifetime risk of AF increases with age but many other risk factors such as diabetes, chronic kidney disease, hypertension and obesity may promote its development. Owing to the shared risk factors, AF and coronary artery disease (CAD) can both be found in the same patient at some point in life [
      • Soliman E.Z.
      • Safford M.M.
      • Muntner P.
      • Khodneva Y.
      • Dawood F.Z.
      • Zakai N.A.
      • et al.
      Atrial fibrillation and the risk of myocardial infarction.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Soliman E.Z.
        • Safford M.M.
        • Muntner P.
        • Khodneva Y.
        • Dawood F.Z.
        • Zakai N.A.
        • et al.
        Atrial fibrillation and the risk of myocardial infarction.
        JAMA Intern Med. 2014; 174: 107-114
        • Gonzalez-Pacheco H.
        • Marquez M.F.
        • Arias-Mendoza A.
        • Alvarez-Sangabriel A.
        • Eid-Lidt G.
        • Gonzalez-Hermosillo A.
        • et al.
        Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation.
        J Cardiol. 2015; 66: 148-154
        • Benjamin E.J.
        • Levy D.
        • Vaziri S.M.
        • D'Agostino R.B.
        • Belanger A.J.
        • Wolf P.A.
        Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
        JAMA. 1994; 271: 840-844
        • Weijs B.
        • Pisters R.
        • Haest R.J.
        • Kragten J.A.
        • Joosen I.A.
        • Versteylen M.
        • et al.
        Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls.
        Heart Rhythm. 2012; 9: 1923-1929
        • Soliman E.Z.
        • Lopez F.
        • O'Neal W.T.
        • Chen L.Y.
        • Bengtson L.
        • Zhang Z.M.
        • et al.
        Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in communities (ARIC) study.
        Circulation. 2015; 131: 1843-1850
        • Meshkat N.
        • Austin E.
        • Moineddin R.
        • Hatamabadi H.
        • Hassani B.
        • Abdalvand A.
        • et al.
        Troponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart review.
        Int J Emerg Med. 2011; 4: 25
        • Jaakkola S.
        • Paana T.
        • Nuotio I.
        • Kiviniemi T.O.
        • Pouru J.P.
        • Porela P.
        • et al.
        Etiology of minor troponin elevations in patients with atrial fibrillation at emergency department-Tropo-AF study.
        J Clin Med. 2019; 8
        • Brown A.M.
        • Sease K.L.
        • Robey J.L.
        • Shofer F.S.
        • Hollander JE.
        The risk for acute coronary syndrome associated with atrial fibrillation among ED patients with chest pain syndromes.
        Am J Emerg Med. 2007; 25: 523-528
        • Clark D.M.
        • Plumb V.J.
        • Epstein A.E.
        • Kay GN.
        Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation.
        J Am Coll Cardiol. 1997; 30: 1039-1045
        • Kochiadakis G.E.
        • Skalidis E.I.
        • Kalebubas M.D.
        • Igoumenidis N.E.
        • Chrysostomakis S.I.
        • Kanoupakis E.M.
        • et al.
        Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
        Eur Heart J. 2002; 23: 734-741
        • Wijesurendra R.S.
        • Liu A.
        • Notaristefano F.
        • Ntusi N.A.B.
        • Karamitsos T.D.
        • Bashir Y.
        • et al.
        Myocardial perfusion is impaired and relates to cardiac dysfunction in patients with atrial fibrillation both before and after successful catheter ablation.
        J Am Heart Assoc. 2018; 7e009218
        • Cai H.
        • Li Z.
        • Goette A.
        • Mera F.
        • Honeycutt C.
        • Feterik K.
        • et al.
        Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke.
        Circulation. 2002; 106: 2854-2858
        • Daoud E.G.
        • Glotzer T.V.
        • Wyse D.G.
        • Ezekowitz M.D.
        • Hilker C.
        • Koehler J.
        • et al.
        Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of trends.
        Heart Rhythm. 2011; 8: 1416-1423
        • Cavallini C.
        • Verdecchia P.
        • Savonitto S.
        • Arraiz G.
        • Violini R.
        • Olivari Z.
        • et al.
        Prognostic value of isolated troponin I elevation after percutaneous coronary intervention.
        Circ Cardiovasc Interv. 2010; 3: 431-435
        • Scheitz J.F.
        • Endres M.
        • Mochmann H.C.
        • Audebert H.J.
        • Nolte C.H.
        Frequency, determinants and outcome of elevated troponin in acute ischemic stroke patients.
        Int J Cardiol. 2012; 157: 239-242
        • Vitolo M.
        • Malavasi V.
        • Proietti M.
        • Diemberger I.
        • Fauchier L.
        • Marin F.
        • et al.
        Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry.
        Eur J Intern Med. 2022; 99: 45-56

      Linked Article